BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20516533)

  • 1. Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south Indians.
    Sandeep S; Gokulakrishnan K; Velmurugan K; Deepa M; Mohan V
    Indian J Med Res; 2010 May; 131():629-35. PubMed ID: 20516533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.
    Lord J; Thomas R; Fox B; Acharya U; Wilkin T
    BJOG; 2006 Oct; 113(10):1203-9. PubMed ID: 16753044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous abdominal adipose tissue is associated with the metabolic syndrome in Asian Indians independent of intra-abdominal and total body fat.
    Goel K; Misra A; Vikram NK; Poddar P; Gupta N
    Heart; 2010 Apr; 96(8):579-83. PubMed ID: 20357386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women.
    Goedecke JH; Wake DJ; Levitt NS; Lambert EV; Collins MR; Morton NM; Andrew R; Seckl JR; Walker BR
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):81-7. PubMed ID: 16817824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese men.
    Oka R; Kobayashi J; Inazu A; Yagi K; Miyamoto S; Sakurai M; Nakamura K; Miura K; Nakagawa H; Yamagishi M
    Metabolism; 2010 May; 59(5):748-54. PubMed ID: 19926101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome.
    O'Gorman CS; Syme C; Lang J; Bradley TJ; Wells GD; Hamilton JK
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):907-13. PubMed ID: 23106295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional body fat distribution and metabolic profile in postmenopausal women.
    Piché ME; Lapointe A; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J; Lemieux S
    Metabolism; 2008 Aug; 57(8):1101-7. PubMed ID: 18640388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
    Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous and total fat at L4-L5 and subcutaneous, visceral and total fat at L3-L4 are important contributors of fasting and postprandial adiponectin levels.
    Katergari SA; Passadakis P; Milousis A; Passadaki T; Asimakopoulos B; Mantatzis M; Prassopoulos P; Tripsianis G; Nikolettos N; Papachristou DN
    Endocr Res; 2015; 40(3):127-32. PubMed ID: 25774471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
    Raji A; Gerhard-Herman MD; Williams JS; O'connor ME; Simonson DC
    Diabet Med; 2006 May; 23(5):537-43. PubMed ID: 16681563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
    Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
    Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between circulating free fatty acids, visceral adipose tissue accumulation, and insulin sensitivity in postmenopausal women.
    Lapointe A; Piché ME; Weisnagel SJ; Bergeron J; Lemieux S
    Metabolism; 2009 Feb; 58(2):180-5. PubMed ID: 19154950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.
    Attallah H; Friedlander AL; Hoffman AR
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S62-7. PubMed ID: 16624603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
    Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.